Articles tagged "Outcome"

2022 American Transplant Congress
Clinical Implications of Robotically Assisted Laparoscopic Donor Nephrectomy: A Single Center Experience
A. Popovic¹, S. Loerzel², M. Hanlon², S. Iskhagi², B. Gallay³, E. Shaban³, J. Leggat³, R. H. Dvorai⁴, S. Narsipur⁵, R. Saidi², R. Shahbazov²
¹College of Medicine, SUNY, Upstate Medical University, Syracuse, NY, ²Surgery, Division of Transplantation, SUNY, Upstate Medical University, Syracuse, NY, ³Medicine, SUNY, Upstate Medical University, Syracuse, NY, ⁴Pathology, SUNY, Upstate Medical University, Syracuse, NY, ⁵SUNY, Upstate Medical University, Syracuse, NY
*Purpose: Robotic assisted live donor nephrectomies (RDN) continue to increase in prevalence over the last years. Prior studies demonstrated outcomes of robotic procedures are no…
2022 American Transplant Congress
Outcome of Kidney Transplantation in the Elderly Compared with Dialysis
B. Shi¹, T. Ying², S. Chadban²
¹University of Sydney, Camperdown, Australia, ²Royal Prince Alfred Hospital, Camperdown, Australia
*Purpose: Although kidney transplantation offers improved survival and quality of life compared to remaining on dialysis for most recipients, outcomes for elderly patients (older than…
2022 American Transplant Congress
Outcomes of Primary Kidney Transplant Recipients with Human Immunodeficiency Virus According to Induction Immunosuppression in the United States
K. Bhunia¹, K. Swanson¹, A. Bregman¹, R. El-Rifai¹, R. Spong¹, S. Jackson², S. Riad³
¹MEDICINE, University of Minnesota, Minneapolis, MN, ²Analytics, MHealth-Fairview, Minneapolis, MN, ³Medicine, University of Minnesota, Minneapolis, MN
*Purpose: Early reports of outcomes in recipients with HIV suggested lower kidney rejection rate in association with depletional induction. However, these reports did not assess…
2022 American Transplant Congress
Lung Transplantation For Covid-19: An International Registry
M. G. Ison¹, R. Giris², O. Dias³, R. Vos⁴, J. Magnusson⁵, T. Zangeneh⁶, E. D. Lease⁷, S. Aslam⁸, M. Weder⁹
¹Northwestern University Comprehensive Transplant Center, Chicago, IL, ²Spectrum Health, Grand Rapids, MI, ³Einstein Hospital, Buenos Aires, Argentina, ⁴UZ Leuven, Leuven, Belgium, ⁵Sahlgrenska Transplant Centre, Stockholm, Sweden, ⁶University of Arizona, Tucscon, AZ, ⁷University of Washington, Seattle, WA, ⁸University of California San Diego, San Diego, CA, ⁹University of Virginia, Charlottesville, VA
*Purpose: SARS-CoV-2 can result in a range of infections from asymptomatic disease to progressive COVID-19 and death. In some patients with COVID-19 Lung Disease (C19LD),…
2022 American Transplant Congress
Outcomes Following Liver Re-Transplantation for Delayed Graft Loss in Recipients of Donation After Circulatory Death Allografts in the United States
S. Kumar¹, S. Lin², J. D. Schold³
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ²Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, ³Center for Populations Health Research, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Donation after circulatory death (DCD) liver transplant (LT) recipients have a higher likelihood of delayed graft loss due to Ischemic cholangiopathy (IC). Limited data…
2022 American Transplant Congress
Distinct Phenotypes of Kidney Transplant Recipients Aged 80 Years or Older in the United States by Machine Learning Consensus Clustering
S. A. Mao¹, C. Thongprayoon², M. A. Mao³, C. C. Jadlowiec⁴, N. Leeaphorn⁵, M. Cooper⁶, W. Cheungpasitporn²
¹Transplant Surgery, Mayo Clinic, Jacksonville, FL, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, ⁴Transplant Surgery, Mayo Clinic, Phoenix, AZ, ⁵Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO, ⁶MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC
*Purpose: Our study aimed to cluster very elderly kidney transplant recipients aged 80 years and above using an unsupervised machine learning approach.*Methods: We performed consensus…
2022 American Transplant Congress
Kidney Transplantation in Mentally Challenged Patients; a Single Center Experience
J. Yagan¹, T. S. Mahmoud¹, O. Gheith¹, P. Nair¹, T. Alotaibi²
¹Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, ²Pathology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait
*Purpose: Kidney transplant is the best choice of treatment for patients with end stage kidney disease. There are medical conditions that may pose an ethical…
2022 American Transplant Congress
Mycophenolate Mofetil-Related Diarrhea and Beta-Glucuronidase Activity Following Kidney Transplantation
G. C. Onyeaghala¹, S. Elmer¹, D. Schladt¹, P. Yang¹, M. Wagner², L. Teigen², M. Al-Kofahi², B. Wu², W. Guan², C. Staley², S. Riad², A. Matas³, R. Remmel², W. Oetting², C. R. Dorr¹, P. Jacobson⁴, A. Israni¹
¹Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, ²University of Minnesota, Minneapolis, MN, ³University of Minnesota Medical School, Minneapolis, MN, ⁴Univ of MN, College of Pharmacy, Minneapolis, MN
*Purpose: The treatment of mycophenolate mofetil (MMF)-related diarrhea in kidney transplants recipients often involves dose reductions, which may result in less effective immunosuppression. We hypothesize…
2022 American Transplant Congress
Safety and Efficacy of Early Central Line Removal in Post Liver Transplant Patients
T. Shamaa¹, E. MacLean¹, O. Shamaa², Z. Lu¹, A. Hinge³, S. Saymuah³, A. Mohamed⁴, T. Kitajima⁴, S. Nagai⁴, M. Rizzari⁴, A. Yoshida⁴, M. Abouljoud⁴, K. Collins⁴
¹General Surgery, Henry Ford Hospital, Detroit, MI, ²Internal Medicine, Henry Ford Hospital, Detroit, MI, ³Wayne State University School of Medicine, Detroit, MI, ⁴Henry Ford Transplant Institute, Detroit, MI
*Purpose: Avoiding central line-associated infections (CLABSIs) is paramount in liver transplant recipients. As a hospital-wide infection control initiative at our institution, early removal of central…
2022 American Transplant Congress
Prevalence of Mycophenolate Mofetil (MMF) Discontinuation and Outcomes in Pediatric Kidney Transplants (PKTX): A PNRC Study
A. Moudgil¹, K. Sgambat¹, E. Benoit², A. Jain³, M. Seifert⁴, C. Katsoufis⁵, L. Harshman⁶, A. Mansuri⁷, M. Somers⁸
¹Nephrology, Children's National Med. Ctr., Washington, DC, ²Nephrology, Boston's Children's Hospital, Boston, MA, ³Nephrology, Wayne State University, Troy, DC, ⁴Nephrology, The University of Alabama, Birmingham, AL, ⁵Nephrology, Holtz Children's Hospital, Miami, FL, ⁶Nephrology, University of Iowa, Iowa City, IA, ⁷Nephrology, Children's Hospital of Georgia, Augusta, GA, ⁸Nephrology, Boston Children's Hospital, Boston, MA
*Purpose: MMF is discontinued in PKTX for various reasons. In this Pediatric Nephrology Research Consortium (PNRC) study, we determined prevalence and reasons for MMF discontinuation…